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ABSTRACT
The incidence of anaerobic bacteraemia was studied retrospectively over 62 months at Mont-Godinne
University Hospital, Yvoir, Belgium. The distribution of organisms, clinical presentations, choice of
antimicrobial therapy and clinical outcome were analysed. The proportion of positive blood cultures
yielding obligate anaerobes was 3.3%. The overall incidence of clinically significant anaerobic
bacteraemia was 0.51 cases ⁄ 1000 patient admissions (0.61 cases ⁄ 10 000 hospital-days), but was signifi-
cantly higher in patients with active haematological malignancies than in other groups (5.97 ⁄ 10 000 vs.
0.33 ⁄ 10 000 hospital-days; p < 0.05). The Bacteroides fragilis group accounted for 61% of isolates,
followed by Clostridium spp. (12.2%), Peptostreptococcus spp. and Leptotrichia spp. (7.3% each) and
Fusobacterium spp. (4.8%). The most common risk-factors were gastrointestinal surgery (49%) and active
haematological malignancies with chemotherapy and ⁄ or bone marrow graft (47%). One or more co-
morbidities were present in 30 (77%) of 39 patients. The lower gastrointestinal tract (41%) and the
oropharynx (23%) were the two most frequent presumed or proven sources for bacteraemia, with
the origin remaining unknown in eight (20.5%) cases. The overall mortality rate (evaluated 7 days after
the occurrence of bacteraemia) was 13%. Fatal outcome correlated with the severity of underlying
diseases and the immunosuppressed status of the patients rather than with the causative pathogen or
the effectiveness of antimicrobial therapy. Likewise, there was no difference in the mortality rate
between patients with monomicrobial and polymicrobial bacteraemia. Overall, the data re-emphasise
the importance of anaerobic bacteraemia, especially in patients with haematological malignancies.
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INTRODUCTION
Anaerobic bacteraemia is uncommon, account-
ing for 0.5–13% of all positive blood cultures
[1–4]. This rate corresponds to an incidence of
0.5–1.0 cases ⁄ 1000 hospital admissions [1,3]. The
need for objective microbiological diagnosis of
anaerobic bacteraemia still remains controver-
sial. It has been proposed that the clinical
characteristics of anaerobic infections should
guide the empirical choice of antimicrobial
therapy [4–6], and the value of performing
anaerobic blood cultures routinely has been
questioned in several recent studies [5,7,8].
However, other studies have shown that anaer-
obic bacteraemia often remains unsuspected on
clinical grounds, and that a substantial propor-
tion of patients with anaerobic bacteraemia do
not receive appropriate antimicrobial treatment
on an empirical basis alone [2,4].
Despite its low incidence, anaerobic bacterae-
mia remains associated with significant mortal-
ity [2–4,9]. Fatal outcome has often been
correlated with age and underlying diseases
[9], as well as with inappropriate antimicrobial
treatment or a delay in starting appropriate
treatment [2,4,10]. The aim of the present study
was to evaluate retrospectively the incidence
and clinical significance of anaerobic bacterae-
mia in a cohort of hospitalised patients, and to
establish whether a shift in frequency and
distribution had occurred.
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METHODS AND MATERIALS
Setting
The Mont-Godinne University Hospital, Yvoir, Belgium, is a
380-bed tertiary-care teaching hospital with several specialised
medical and surgical clinics, including cardiovascular, thoracic,
orthopaedic, abdominal and neurosurgical wards. Facilities
include a large pulmonary diseases unit (55 beds), a geriatric
ward (30 beds), three medical-surgical intensive care units (24
beds), and a large oncology and haematology department that
serves as a reference centre for haematological diseases in
southern Belgium (provinces of Namur and Luxembourg). The
haematology unit comprises 20 beds, six rooms with laminar
flow, and ten rooms with positive pressure. Approximately 45
bone marrow transplants are performed annually.
Patients
Patients with blood cultures positive for anaerobic bacteria in
the 62-month period between 21 January 1999 and 15 March
2004 were identified retrospectively from laboratory records.
The hospital records of these patients were reviewed by a
microbiologist, an infectious disease physician and a haematol-
ogist. Data were collected concerning age, gender, underlying
diseases, empirical antimicrobial treatment and eventual chan-
ges in therapy when bacteriological results became available,
proven or presumed foci of anaerobic bacteraemia, and out-
come.
Bacteraemia was deemed to be clinically significant when
the patient had one or more blood cultures positive for
anaerobes and met one of the following criteria: leukocyte
count < 100 ⁄mm3 or > 10 000 ⁄mm3; temperature > 38C; or a
physical examination or pathological or surgical evidence
consistent with infection (e.g., isolation of anaerobes from a
source other than blood, or evidence of barrier compromise).
Potential contaminants (e.g., Propionibacterium spp.) that grew
in only one of several blood cultures were discarded.
The source of infection was determined by radiological,
surgical or microbiological evidence of barrier compromise, or
an infectious pathology, such as abscess or necrosis. A
bacteraemic episode was considered to be polymicrobial if
two or more non-contaminant species were isolated from
blood simultaneously or within 1 week of the initial blood
culture positive for anaerobes. Based on National Nosocomial
Infection Surveillance System guidelines, infections were
deemed nosocomial if the positive blood culture was drawn
>48 h after admission to the hospital [11].
Antimicrobial treatment was considered to be appropriate if
the agents used for therapy had a spectrum of activity
providing coverage for anaerobes and were found to be
effective by in-vitro susceptibility testing.
Mortality was attributed to anaerobic bacteraemia when a
patient died from uncontrolled sepsis within 7 days of
the onset of the episode, in the absence of other non-infectious
co-morbidities.
Cultures
Blood cultures were analysed with a BacT ⁄Alert 240 system
(bioMe´rieux, Marcy l’Etoile, France) following inoculation of
5–10 mL of blood into aerobic and anaerobic vials (BacT ⁄Alert
FA and SN bottles; bioMe´rieux). Blood culture bottles were
incubated for a maximum of 5 days at 37C with constant
shaking. Positive anaerobic bottles were subcultured on tryptic
soya agar containing sheep blood 5% v ⁄v, and on Schaedler
agar containing horse blood 5% v ⁄v, and were incubated in an
anaerobic atmosphere with an Anoxomat WS 80 device (Mart
BV, Lichtenvoorde, The Netherlands). Bacterial colonies were
identified by standard methods [12] and with an API 20A
system (bioMe´rieux). Antibiotic susceptibility testing was
performed by disk-diffusion [13] or Etest (AB Biodisk, Solna,
Sweden) on Brucella blood agar supplemented with haemin
5 mg ⁄L and vitamin K1 1 mg ⁄L) [14]. Disk inhibition zones
were interpreted according to the guidelines of the Comite´
Franc¸ais de l’Antibiogramme [13], and MIC values were
interpreted according to CLSI (formerly NCCLS) guidelines
[15].
Blood culture results were entered into a computerised
laboratory database that allowed ward personnel to read the
results as they became available. Information concerning pos-
itive blood culture results was also telephoned to clinicians as
soon as the positive culture was identified, with simultaneous
transmission to a consultant infectious diseases physician.
RESULTS
Overall, 4857 of 51 782blood cultureswerepositive
during the study period. Of the microorganisms
isolated, 98.1% were bacteria (facultative anaer-
obes, 88.6%; Gram-negative non-fermentative bac-
teria, 6.2%; strict anaerobes, 3.3%) and 1.9% were
fungi. The contamination rate was 2.5%. Blood
cultures from 47 patients yielded 49 strict anaer-
obes (representing 3.3% of all episodes of bacter-
aemia). After review of the medical records,
anaerobic bacteraemia was considered clinically
significant in 39 patients (0.51 cases ⁄ 1000 admis-
sions). Blood cultures from two patients yielded
mixed growth of two different organisms, so that
41 obligate anaerobes were isolated in total. Two
major groups of patients presentingwith anaerobic
bacteraemia were identified: (1) patients with
active haematological malignancies (n = 18); and
(2) patients with various other clinical conditions
(n = 21), including patients with a history of solid
neoplasm (Table 1).
The mean incidence rate of anaerobic bacterae-
mia between 1999 and 2003 was 5.87 ⁄ 10 000 days
of hospitalisation (95% CI, 2.54–9.20) for patients
with haematological malignancies, compared
with 0.33 ⁄ 10 000 days of hospitalisation
(95% CI, 0.08–0.57) for other patient groups
(p 0.0077 with T-test; Fig. 1). The total number
of annual admissions, as well as the number of
blood cultures obtained between 1999 and 2003,
remained unchanged, while there was a linear
trend towards an increased incidence of anaerobic
bacteraemia during the study period
528 Clinical Microbiology and Infection, Volume 12 Number 6, June 2006
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 527–532
(0.92 ⁄ 1000 patients in 2003 vs. 0.37 ⁄ 1000 patients
in 1999; p 0.057). The mean age of the patients
was 61.2 years (SD 15.3 years; range 23–85 years),
and the male to female ratio was 1.6 (24 males).
Twenty-five (64%) of the 39 patients presented
with at least one co-morbidity, and 12 (31%)
patients had two or more underlying diseases. The
most frequent co-morbidities were cardiovascular
or respiratory disease (59%), haematological
malignancy (46%), solid neoplasms (15.4%), dia-
betes mellitus (5%), and others (8%). Nineteen
(48.7%) patients had gastrointestinal disorders or
recent surgery of the digestive tract. Episodes of
anaerobic bacteraemia were deemed nosocomial
for 15 (83.3%) patients with haematological malig-
nancies, and for 12 (57.1%) patients from the other
groups. For 13 haematological patients, the
elapsed time between the onset of neutropenia
(< 100 white blood cells ⁄mm3) and the episode of
bacteraemia was 0–161 days (median 11 days;
95% CI, 2–47.8 days). The different groups and
species of organisms, arranged according to
patient category and by presumed or proven
sources of infection, are shown in Table 2. Overall,
Bacteroides spp. and Clostridium spp. accounted for
75% of all reported cases of anaerobic bacterae-
mia. Episodes of anaerobic bacteraemia caused by
Clostridium tertium, Fusobacterium spp. and Lepto-
trichia spp. were found exclusively among neu-
tropenic patients with haematological dyscrasias,
and were associated essentially with an oral or
orodental portal of entry.
Altogether, the lower gastrointestinal tract
(17 ⁄ 39 patients; 43.6%) was the most common
proven or presumed portal of entry, and was
associated with widely diverse clinical conditions,
such as biliary tract infections, gut ischaemia,
sigmoiditis, appendicitis, diverticulitis, peritonitis
and neutropenic colitis (Table 1). The oropharynx
and orodental systems (n = 9; 23%) constituted
the second most frequent origins of anaerobic
bacteraemia, especially in patients with haemato-
logical malignancies. In particular, necrotic gingi-
vitis, mucositis or dental abscesses were
documented frequently in this group of patients
(Table 1). Episodes of anaerobic bacteraemia asso-
ciated with infected wounds and decubitus ulcers
were also quite common and were documented in
eight patients. In one patient, the source of
bacteraemia was a lumbo-sacral spondylodiscitis
following vertebral surgery. No primary focus of
infection could be detected for eight (20.5%)
Table 1. Characteristics of patients with anaerobic blood-
stream infections, stratified by group of patients
Haematological
group
(n = 18)
Non-haematological
group
(n = 21)
Male, n 11 13
Female, n 7 8
Gender ratio, male ⁄ female 1.57:1 1.62:1
Age, years, mean ± SD (min.–max.) 56.8 ± 13.9 (23.5–80.9) 64.9 ± 15.7 (35.1–85.7)
Nosocomial infection, n (%) 15 (83) 12 (57)
Community infection, n (%) 3 (17) 9 (43)
Non-survivors, n (%) 3 (17) 2 (9.5)
ICU stay, n 2 4
Haematological disease, n
Acute myeloid leukaemia 6 –
Myeloma 3 –
Myelodysplastic syndrome 3 –
Acute lymphoid leukaemia 2 –
Chronic lymphoid leukaemia 1 –
Lymphoma 3 –
Chemotherapy, n 17 0
Bone marrow transplant, n 5 –
Autograft 4 –
Allograft 1 –
Neutropenia, n 13 0
Portal of entry ⁄ focus, n
Not found 6 2
Decubitus ulcer 1 3
Sacrum decubitus bedsore 1 2
Vertebral osteomyelitis 1
Amygdalitis 1 1
Mucositis, necrotic gingivitis 4 –
Dental abscess, dental care 1 1
Post-operative cervical
wound infection
– 1
Abdominal gunshot wound – 1
Appendicitis – 2
Biliary tract infection – 3
Gut haemorrhage 2 –
Gut ischaemia – 1
Diverticulitis – 2
Sigmoiditis 1 –
Neutropenic enterocolitis 1 –
Peritonitis 1 1
Days between admission and
positivity, median
(95% CI; min.–max.)
13 (5.00–21.32; 0–63) 4 (0.02–13.98; 0–204)
Pure anaerobic culture, n (%) 9 (50) 16 (76)
Mixed aerobic–anaerobic
culture, n (%)
9 (50) 5 (24)
Enterobacteriaceae 22 (4) 4 (19)
Streptococcus ⁄Enterococcus 22 (4) 2 (10)
Other 2 (11) –
ICU, intensive care unit.
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Fig. 1. Incidence of anaerobic bacteraemia, stratified by
hospital unit.
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patients (six (33%) in the haematological
group and two (10%) in the other groups of
patients).
Fourteen (36%) of all episodes of anaerobic
bacteraemia presented as polymicrobial infec-
tions, with Enterobacteriaceae, streptococci and
enterococci being the pathogens involved most
frequently (Table 1). Polymicrobial mixed infec-
tions were found more frequently among patients
with haematological disorders (n = 9; 50%) than
among the other patient groups (n = 5; 23.8%).
Overall, most patients were receiving broad-
spectrum antibiotics as empirical therapy at the
onset of the episode of anaerobic bacteraemia.
Antibiotic therapy was documented for 37 pa-
tients, of whom 24 received appropriate effective
broad-spectrum antimicrobial therapy with cov-
erage for anaerobes before the results of blood
cultures were known. Initial empirical antibiotic
therapy was changed for ten (27%) patients
following the blood culture results. Two patients
did not receive any antibiotics, but nevertheless
had a favourable clinical outcome following
surgical drainage. One patient with a bacteraemia
caused by Bacteroides fragilis and an infected
decubitus ulcer recovered uneventfully despite
the administration of cefepime, an antibiotic with
impaired coverage for anaerobes.
Five patients died during hospitalisation (a
crude mortality rate of 13%). There was no
difference in the mortality rate between patients
with monomicrobial or polymicrobial bacterae-
mia (2 ⁄ 14, 14.3% vs. 3 ⁄ 25, 12%). None of the
fatal cases could be linked directly to the
anaerobic bacteraemia or to an inappropriate
choice of antibiotic therapy. Three of the
patients with a fatal outcome had severe uncon-
trolled active haematological disease (two pa-
tients with acute-phase leukaemia; one patient
with aggressive lymphoma). One patient with
chronic renal failure had a ruptured abdominal
aortic aneurysm, and died from ischaemic colitis
with anaerobic-related sepsis. The last non-sur-
vivor was a comatose geriatric patient with
multiple organ failure, ionic disorders, and a
sacral decubitus abscess as the probable source
of bacteraemia.
DISCUSSION
Underlying diseases are reported frequently as
risk-factors for anaerobic bacteraemia, partic-
ularly malignancies, liver failure, diabetes melli-
tus or previous gastrointestinal surgery [3,4,8,9].
In the present study, gastrointestinal pathologies
or recent bowel surgery were confirmed as poten-
tial risk-factors, while diabetes mellitus and hep-
atic diseases were encountered rarely. A striking
feature was that almost half of the patients with
an episode of anaerobic bacteraemia presented
with an active haematological disease at the time
of infection.
Table 2. Anaerobic microorganisms
isolated from episodes of blood-
stream infections occurring among
haematological and non-haemato-
logical patients
Bacteria n (%)
Haematological
patients
Non-
haematological
patients Focus Associated bacteria
Bacteroides fragilis group
Bacteroides fragilis
Bacteroides diastonis
Bacteroides ovatus
Bacteroides uniformis
Bacteroides vulgatus
Bacteroides stercoris
25 (61)
19
2
1
1
1
1
9
7
1
1
16
12
2
1
1
OR, D, V
D
D
D
Streptococcus anginosus,
Streptococcus sanguis,
Enterococcus faecium,
coagulase-negative
staphylococci,
Enterobacter aerogenes,
Escherichia coli,
Clostridium perfringens
Bacteroides ureolyticus 1 (2.4) 1 OR Escherichia coli,
Streptococcus constellatus,
Peptostreptococcus
Prevotella intermedia 1 (2.4) 1 D Streptococcus mitis
Leptotrichia spp. 3 (7.3) 3 OR None
Fusobacterium spp. 2 (4.9) 2 OR Klebsiella pneumoniae
Clostridium spp. 5 (12.2) None
Clostridium perfringens 2 2 D Proteus vulgaris,
Escherichia coli,
Bacteroides fragilis
Clostridium tertium 3 3 OR, D Streptococcus mitis,
Klebsiella oxytoca,
Escherichia coli
Peptostreptococcus spp. 3 (7.3) 3 D, OR Escherichia coli,
Morganella morganii,
Bacteroides ureolyticus
Bifidobacterium spp. 1 (2.4) 1 D None
Total 41 (100) 18 23
OR, oropharynx or dental; D, digestive; V, various others.
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The crude mortality rate associated with anaer-
obic bacteraemia has been shown to range
between 13% and 45% [2–4,9,16,17], and is
usually found to correlate closely with the age
of the patients and the severity of co-morbidities
[2–4,9]. It is also acknowledged that bloodstream
infections caused by the B. fragilis group are
associated with a higher rate of mortality, prob-
ably reflecting the higher virulence of these
organisms [9,17,18]. In the present series, mortal-
ity could not be attributed directly to the bacter-
aemia in any of the five fatal cases, since each
patient died from well-documented non-infec-
tious causes.
In contrast with previous reports [10,17,19], a
higher mortality rate was not found among
patients who were treated inadequately. How-
ever, this may relate to the fact that most patients
in the present study received effective empirical
therapy with anaerobic coverage at the onset of
their infection. Moreover, antimicrobial regimens
were modified rapidly by the attending infectious
diseases physicians, according to bacteriological
results, for those patients who were not receiving
effective empirical therapy.
Although several studies have reported a
marked decline in the incidence of anaerobic
bacteraemia and have questioned the value of
routine anaerobic blood cultures [1,5,7,20], the
present study observed a rising trend in the
number of episodes of anaerobic bacteraemia
and ⁄ or septicaemia, increasing from
0.37 ⁄ 1000 patients in 1999 to 0.92 ⁄ 1000 patients
in 2003 (p 0.057). The total number of blood
cultures assessed did not change significantly
during this period, and the culture media and
blood culture system used remained the same.
Moreover, the overall population profile and
patient-mix did not change and, in particular,
the number of bone marrow transplant recipients
remained stable. In a similar study, Lark et al. [16]
also reported a rising incidence of anaerobic
bacteraemia among patients with bone marrow
transplants, with episodes of anaerobic bacterae-
mia occurring at a high frequency of 4 ⁄ 100 bone
marrow transplant procedures, accounting for
17% of all episodes of bacteraemia during the
study period.
The present retrospective study observed some
significant differences between episodes of
anaerobic bacteraemia in patients with active
haematological malignancies compared with
non-haematological patients. First, the incidence
of anaerobic bloodstream infections was signifi-
cantly higher in patients with haematological
malignancies. Second, the oropharynx was shown
to be the most frequent primary source of anaer-
obic bacteraemia in neutropenic patients with
acute haematological malignancies while, as
reported previously [3,4,9], the lower gastrointes-
tinal tract represented the most common portal of
entry for bacteraemia in the general population.
Overall, B. fragiliswas themost common pathogen
causing anaerobic bacteraemia (61%), and was
found mainly in association with gastrointestinal
tract infections or in the context of infected decub-
itus ulcers. In contrast, episodes of bacteraemia
involving specific anaerobic organisms, e.g., Fuso-
bacterium spp., Leptotrichia spp. and C. tertium,
were found exclusively among neutropenic bone
marrow transplant recipients who had good evi-
dence of barrier compromise (severe oralmucositis
(grade II or III) and ⁄ or enterocolitis).
Almost half of the episodes of anaerobic bac-
teraemia occurring in haematological patients
were polymicrobial and were associated with
non-anaerobic bacteria, originating mostly from
the oral or intestinal flora. This observation is in
line with previous reports showing that poly-
microbial mixed infections involving anaerobic
bacteria occur at a higher frequency than mono-
microbial episodes in neutropenic patients [16].
In summary, a trend towards a rising incidence
of anaerobic bacteraemia was identified in the
present study. Almost half of the affected indi-
viduals were patients with haematological dys-
crasia (acute leukaemia or lymphoma) who had
received bone marrow transplants and ⁄ or high
doses of chemotherapy at or before the time of the
infection. In this group of severely immunocom-
promised patients with neutropenia, the oral
cavity (mucositis, gingivitis) was the most fre-
quent putative source of anaerobic bacteraemia,
while the gastrointestinal tract was the most
common portal of entry in the general non-
haematological population. As a consequence,
the distribution of the causative pathogens dif-
fered substantially between the two groups of
patients. Moreover, haematological patients had
bacteraemia caused by mixed anaerobic and
facultative oral or intestinal bacteria more fre-
quently, suggesting erosions in the mucosal bar-
riers. Finally, no correlation could be established
between the appropriateness of the antimicrobial
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treatment of the bacteraemia and the clinical
outcome, thereby emphasising the primary
importance of patients’ co-morbidities and ⁄ or
immune status in the outcome of these infections.
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